Price movement over the last 24 hours
American Well Corp vs TJX Companies Inc — how do they compare? American Well Corp trades at $9.9 (market cap $165.58M), while TJX Companies Inc trades at $151.56 (market cap $167.19B). The key difference: TJX Companies Inc is far larger — about 1009.7× American Well Corp's market cap, and TJX Companies Inc pays a 1.27% dividend while American Well Corp pays none. Which is the better fit depends on your goals.
| AMWL | TJX | |
|---|---|---|
Market Cap | $165.58M | $167.19B |
Sector | Health | Consumer Cyclical |
52-Week High | $9.91 | $168.41 |
52-Week Low | $3.78 | $121.35 |
Enterprise Value | -$9.66M | $175.79B |
Dividend Yield | — | 1.27% |
Signals from Pluang's Aura AI — not financial advice
AMWL trades at $9.91, up 8.66% today, with bullish technical signals and positive momentum. The company shows improving financial trends with declining losses and strong gross margins of 52.9%, though it remains unprofitable with a -37.02% net margin. Recent news highlights Amazon's appointment of Amwell's co-founder to lead its healthcare unit, signaling industry validation.
While AMWL shows operational improvement and attractive valuation multiples (P/S 0.68, P/B 0.73), the stock faces headwinds from persistent losses and negative cash flow. Analyst consensus is cautious with a $7.25 price target below current levels, suggesting limited near-term upside despite recent positive momentum.
TJX trades at $151.34, showing modest daily gains amid a bearish technical signal. The company demonstrates strong fundamentals with consistent earnings beats, including Q1 2026 EPS of $1.19 versus $1.02 expected, and robust profitability metrics like a 61.25% ROE. Revenue growth is steady, climbing from $48.5B in 2022 to $56.4B in 2025, with further expansion projected. Recent news highlights TJX's resilience as a blue-chip retailer during market volatility, though technical indicators suggest near-term pressure.
The outlook for TJX remains positive based on fundamental strength and analyst optimism, with a consensus price target of $181.80 implying significant upside. Key opportunities include international expansion and same-store sales growth. Risks involve competitive retail pressures and macroeconomic sensitivity. Wall Street sentiment is overwhelmingly bullish, with 88% of analysts rating it a Buy, supporting a favorable long-term investment case despite short-term technical weakness.
Trailing returns across standard periods
American Well Corp is a telehealth company enabling digital delivery of care for its customers. Its platform, Amwell, digital care delivery solution that equips health systems, health plans, government, and innovator clients with the tools to enable new models of care for their patients and members enabling care delivery across the full healthcare continuum - from primary and urgent care in the home to high acuity specialty consults, such as telestroke and telepsychiatry, in the hospital. It provides both on-demand and scheduled consultations. Its Health Plan Programs include Virtual Primary Care, Musculoskeletal Care, Dermatology Care, and Chronic Care among others and its Health System Modules include Acute Behavioral Health, ED Triage, Pediatrics and Telestroke among others.
Read more on AMWL →TJX is a leading off-price retailer of apparel, home fashions, and other merchandise. It sells a variety of branded goods, opportunistically buying inventory from a network of over 21,000 vendors worldwide. TJX targets undercutting conventional retailers' regular prices by 20%-60%, capitalizing on a flexible merchandising network, relatively low-frills stores, and a treasure-hunt shopping experience to drive margins and inventory turnover. TJX derived 79% of fiscal 2022 revenue from the United States, with 11% from Europe (mostly the United Kingdom and Germany), 9% from Canada, and the remainder from Australia. The company operated 4,689 stores at the end of fiscal 2022 under the T.J. Maxx, T.K. Maxx, Marshalls, HomeGoods, Winners, Homesense, Winners, and Sierra banners.
Read more on TJX →